Author

Thenappan A

University of Minnesota - Cited by 7,371 - Pulmonary Hypertension

Biography

2White Memorial Medical Center, Los Angeles, USA. Physiological Basis of Alternative Therapies to Alleviate Sleep Disturbances. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension
Title
Cited by
Year
Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry
KY Chang, S Duval, DB Badesch, TM Bull, MM Chakinala, T De Marco, ...Journal of the American Heart Association 11 (9), e024969, 2022202
40
2022
Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial
D Burkhoff, BA Borlaug, SJ Shah, R Zolty, RJ Tedford, T Thenappan, ...Heart Failure 9 (5), 360-370, 2021202
40
2021
With no lysine kinase 1 promotes metabolic derangements and RV dysfunction in pulmonary arterial hypertension
SZ Prisco, M Eklund, R Raveendran, T Thenappan, KW PrinsBasic to Translational Science 6 (11), 834-850, 2021202
17
2021
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association …
HM DuBrock, CD Burger, SD Bartolome, JP Feldman, DD Ivy, ...Pulmonary circulation 11 (3), 20458940211020913, 2021202
17
2021
Intermittent fasting enhances right ventricular function in preclinical pulmonary arterial hypertension
SZ Prisco, M Eklund, DM Moutsoglou, AR Prisco, A Khoruts, EK Weir, ...Journal of the American Heart Association 10 (22), e022722, 2021202
15
2021
Inflammatory glycoprotein 130 signaling links changes in microtubules and junctophilin-2 to altered mitochondrial metabolism and right ventricular contractility
SZ Prisco, LM Hartweck, L Rose, PDA Lima, T Thenappan, SL Archer, ...Circulation: Heart Failure (1), e008574, 2022202
15
2022
ISHLT consensus statement: Peri-operative management of patients with pulmonary hypertension and right heart failure undergoing surgery
D McGlothlin, J Granton, W Klepetko, M Beghetti, EB Rosenzweig, ...The Journal of Heart and Lung Transplantation, 2022202
13
2022
Prediction of health-related quality of life and hospitalization in pulmonary arterial hypertension: the Pulmonary Hypertension Association Registry
J Min, D Badesch, M Chakinala, J Elwing, R Frantz, E Horn, J Klinger, ...American journal of respiratory and critical care medicine 203 (6), 761-764, 2022202
13
2022
Elevated pulmonary pressure noted on echocardiogram: a simplified approach to next steps
MK Kanwar, RJ Tedford, T Thenappan, T De Marco, M Park, ...Journal of the American Heart Association (7), e017684, 2021202
10
2021
Association between digoxin use and gastrointestinal bleeding in contemporary continuous flow left ventricular assist device support
A El Rafei, BH Trachtenberg, J Schultz, R John, JD Estep, ...The Journal of Heart and Lung Transplantation 40 (7), 71-7, 2021202
6
2021
Incidence and risk factors of pulmonary hypertension after venous thromboembolism: an analysis of a large health care database
PL Lutsey, LH Evensen, T Thenappan, KW Prins, RF Walker, JF Farley, ...Journal of the American Heart Association 11 (14), e024358, 2022202
6
2022
Pulmonary arterial hypertension patients have a proinflammatory gut microbiome and altered circulating microbial metabolites
DM Moutsoglou, J Tatah, SZ Prisco, KW Prins, C Staley, S Lopez, M Blake, ...American journal of respiratory and critical care medicine 207 (6), 740-76, 2023202
5
2023
Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry
KY Chang, S Duval, DB Badesch, TM Bull, MM Chakinala, T De Marco, ...D3. D003 COME TOGETHER-CLINICAL ADVANCES IN PULMONARY HYPERTENSION: LESSONS …, 2021202
5
2021
Iron deficiency is associated with more severe pulmonary vascular disease in pulmonary hypertension caused by chronic lung disease
J Tatah, JL Keen, SZ Prisco, M Pritzker, T Thenappan, KW PrinsChest 161 (1), 232-236, 2022202
5
2022
A case report of portopulmonary hypertension precipitated by transjugular intrahepatic portosystemic shunt
JH Tatah, EK Weir, KW Prins, T ThenappanChest 159 (), e193-e196, 2021202
4
2021
External assessment of the EUROMACS right-sided heart failure risk score
H Shah, T Murray, J Schultz, R John, CM Martin, T Thenappan, ...Scientific reports 11 (1), 1606, 2021202
4
2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the …
J Minhas, SP Narasimmal, T M. Bull, TD Marco, JW McConnell, ...Pulmonary circulation 11 (4), 2045894021105196, 2021202
3
2021
Shifting gears: the search for group 3 pulmonary hypertension treatment
JL Keen, T ThenappanCurrent Opinion in Pulmonary Medicine 7 (5), 96-30, 010
2
2021
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension …
HM DuBrock, CD Burger, SD Bartolome, JP Feldman, DD Ivy, ...Pulmonary circulation 1 (4), e117, 0
2
2022
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
A Waxman, R Restrepo-Jaramillo, T Thenappan, P Engel, A Bajwa, ...European Respiratory Journal 61 (6), 030
2
2023

Referred From: https://scholar.google.com/citations?user=bFnfA1AAAAAJ&hl=en

Cited by
Citations 7371
h-index 40
i10-index 93
Recommended Journals
Open Access Journals